BioSpace News Archive

Aesthetic Medical International Holdings Group Limited, a leading provider of aesthetic medical services in China, announces its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2020.

aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, and the Foundation for Sarcoidosis Research (FSR), the leading international nonprofit organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients,

180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the “Company”), a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that all patient data for the Phase 2b Dupuytren’s disease clinical trial has been collected and submitted for analysis and review.

Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced that it has appointed Professor Robert S. Langer, Sc.D., as Chairman of its Scientific Advisory Board.

Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced the closing of the sale of Coherus common stock to Junshi Biosciences. Under the terms of the February 2, 2021 stock purchase agreement, Coherus has received $50 million from Junshi Biosciences’ acquisition of 2,491,988 shares at a price per share of $20.06.

Aveanna Healthcare Holdings Inc. (“Aveanna”) today announced that it has launched its initial public offering of 38,236,000 shares of its common stock at an anticipated initial public offering price between $16.00 and $18.00 per share pursuant to a registration statement on Form S-1 previously filed with the U.S. Securities and Exchange Commission (“SEC”).

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces new enabling technologies for its INTELLIO™ Connected Tower Solution with the introduction of the DOUBLEFLO™ Inflow/Outflow Pump* and 4KO™ (Optimized) Arthroscopes and Laparoscopes.

LimaCorporate is proud to announce the first surgery performed in the SMR Stemless Reverse Shoulder System Investigational Device Exemption (IDE) study.

On April 10th, leading manufacturer of medical and aesthetic lasers and light source technologies, Sciton Inc., hosted over 650 medical professionals at its 2021 Rockstars of Aesthetics Virtual Summit.

Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced three key appointments to its Board of Directors: Meryl Zausner, former U.S. Senator William “Mo” Cowan and Tyrell Rivers, Ph.D. Ms. Zausner will also serve as Chair of the company’s Audit Committee.